|
|
|
|
 Grifols Biologicals |
|
Grifols Biologicals researches, develops and produces therapeutic proteins from human plasma.
Grifols Biologicals uses the most cutting-edge technology for protein purification.
Our modern facilities are organized according to Good Manufacturing Procedures (GMP) and have been certified under the FDA Establishment License.
Grifols Biologicals’ plant in Los Angeles (California, USA) has a total production capacity of 1.5 million liters per year. In order to meet growing demands for plasma derivatives on a world wide scale and continue expanding internationally, we are in the process of expanding the capacity of the L.A. plant by 700,000 liters. This move will consolidate Grifols’ position as one of the largest plasma fractionators in the world.
At Grifols Biologicals, we invest significant resources in research and development.
Our mission is to offer new therapeutic options in the form of quality products that are both effective and safe.
Grifols Biologicals
5555 Valley Boulevard
Los Angeles. California 90032. USA
Tel. (800) 421-0008
Fax.(323) 227-7428
|
| |
|
|
